Rapamycin Reduces Amyloid‐β Plaques and Improves Behavioral Performance in a Sex‐Dependent Manner in Mouse Models of Amyloidosis
CNS Neuroscience & Therapeutics · 2026
DOI: 10.1002/cns.70807 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Shihui Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Sirolimus, Plaque, Amyloid, Amyloidosis, Sex Characteristics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, National Natural Science Foundation of China, Lingang Laboratory.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD), the most common form of dementia, lacks effective disease‐modifying treatments. Rapamycin, an mTOR inhibitor with immunomodulatory properties, may mitigate AD pathology by restoring microglial functions.
Methods
Rapamycin was orally administered to 2‐month‐old 5xFAD and hAPP NL ‐G‐F mice (amyloid plaque‐dominant AD models). At 5 months of age, these mice were subjected to behavioral, histopathological, and molecular analyses. To assess microglial function, primary microglia were treated with rapamycin and evaluated for their ability to phagocytose and degrade fluorescently labeled amyloid‐β (Aβ) via the IncuCyte real‐time imaging system. Furthermore, the effects of rapamycin and autophagy inhibitors on lipid droplet content were analyzed in oleic acid‐treated BV2 microglial cells using flow cytometry and confocal microscopy.
Results
Rapamycin treatment reduced the cerebral Aβ plaque burden, alleviated dystrophic neurites, suppressed glial hyperactivation, and increased plaque‐associated microglial density in both mouse models, with more pronounced effects in female mice. These pathological improvements were associated with attenuated deficits in hippocampal‐dependent memory tasks (spontaneous alternation in the Y‐maze and contextual fear conditioning tasks). Mechanistically, rapamycin enhances microglial lysosomal degradation, promotes lipid droplet clearance in BV2 cells, and increases Aβ phagocytic clearance in primary microglial cells.
Conclusions
Our findings suggest that rapamycin reduces amyloid pathology and associated behavioral deficits in AD mice, an effect associated with enhanced microglial lysosomal activity and Aβ clearance, highlighting its therapeutic potential in AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
- Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Förderung
- STI2030-Major Projects
- National Natural Science Foundation of China
- Lingang Laboratory
- Science and Technology Research Program of Chongqing Municipal Education Commission
- Natural Science Foundation of Chongqing
- CQMU Program for Youth Innovation in Future Medicine
- Chongqing Graduate Student Research Innovation Project
- Natural Science Foundation of Fujian Province
Zitieren
APA
Guo, S., Fu, W., Wang, Y., Liu, Q., Li, J., Guo, K., & Zhang, H. (2026). Rapamycin Reduces Amyloid‐β Plaques and Improves Behavioral Performance in a Sex‐Dependent Manner in Mouse Models of Amyloidosis. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70807
Vancouver
Guo S, Fu W, Wang Y, Liu Q, Li J, Guo K, et al. Rapamycin Reduces Amyloid‐β Plaques and Improves Behavioral Performance in a Sex‐Dependent Manner in Mouse Models of Amyloidosis. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70807
BibTeX
@article{Guo2026,
author = {Guo, Shihui and Fu, Weishan and Wang, Yating and Liu, Qi and Li, Jiaxin and Guo, Kai and Zhang, Hongsheng},
title = {Rapamycin Reduces Amyloid‐β Plaques and Improves Behavioral Performance in a Sex‐Dependent Manner in Mouse Models of Amyloidosis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
doi = {10.1002/cns.70807}
}
EUVIMED